List of Excipients in API travoprost ophthalmic solution
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing travoprost ophthalmic solution
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Micro Labs Limited | travoprost ophthalmic solution | 42571-130 | BORIC ACID |
| Micro Labs Limited | travoprost ophthalmic solution | 42571-130 | CASTOR OIL |
| Micro Labs Limited | travoprost ophthalmic solution | 42571-130 | HYDROCHLORIC ACID |
| Micro Labs Limited | travoprost ophthalmic solution | 42571-130 | POLYOXYL 40 HYDROGENATED CASTOR OIL |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for travoprost ophthalmic solution
Excipient focus: BENZALKONIUM CHLORIDE
travoprost ophthalmic solution drug variants containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Inc | travoprost ophthalmic solution usp, 0.004% | 62332-510 |
| >Company | >Ingredient | >NDC |
travoprost ophthalmic solution drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | travoprost ophthalmic solution | 42571-130 |
| Gland Pharma Limited | travoprost ophthalmic solution | 68083-601 |
| Mylan Pharmaceuticals Inc | travoprost ophthalmic solution, 0.004% | 0378-9651 |
| >Company | >Ingredient | >NDC |
Excipient focus: BORIC ACID
travoprost ophthalmic solution drug variants containing BORIC ACID
travoprost ophthalmic solution drug variants not containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CASTOR OIL
travoprost ophthalmic solution drug variants containing CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | travoprost ophthalmic solution | 42571-130 |
| >Company | >Ingredient | >NDC |
travoprost ophthalmic solution drug variants not containing CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| Gland Pharma Limited | travoprost ophthalmic solution | 68083-601 |
| Alembic Pharmaceuticals Inc | travoprost ophthalmic solution usp, 0.004% | 62332-510 |
| Mylan Pharmaceuticals Inc | travoprost ophthalmic solution, 0.004% | 0378-9651 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
travoprost ophthalmic solution drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Inc | travoprost ophthalmic solution usp, 0.004% | 62332-510 |
| >Company | >Ingredient | >NDC |
travoprost ophthalmic solution drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | travoprost ophthalmic solution | 42571-130 |
| Gland Pharma Limited | travoprost ophthalmic solution | 68083-601 |
| Mylan Pharmaceuticals Inc | travoprost ophthalmic solution, 0.004% | 0378-9651 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
travoprost ophthalmic solution drug variants containing HYDROCHLORIC ACID
travoprost ophthalmic solution drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
travoprost ophthalmic solution drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Inc | travoprost ophthalmic solution usp, 0.004% | 62332-510 |
| >Company | >Ingredient | >NDC |
travoprost ophthalmic solution drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | travoprost ophthalmic solution | 42571-130 |
| Gland Pharma Limited | travoprost ophthalmic solution | 68083-601 |
| Mylan Pharmaceuticals Inc | travoprost ophthalmic solution, 0.004% | 0378-9651 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL
travoprost ophthalmic solution drug variants containing POLYOXYL 40 HYDROGENATED CASTOR OIL
travoprost ophthalmic solution drug variants not containing POLYOXYL 40 HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
travoprost ophthalmic solution drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | travoprost ophthalmic solution | 42571-130 |
| Gland Pharma Limited | travoprost ophthalmic solution | 68083-601 |
| Mylan Pharmaceuticals Inc | travoprost ophthalmic solution, 0.004% | 0378-9651 |
| >Company | >Ingredient | >NDC |
travoprost ophthalmic solution drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Inc | travoprost ophthalmic solution usp, 0.004% | 62332-510 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
travoprost ophthalmic solution drug variants containing SODIUM HYDROXIDE
travoprost ophthalmic solution drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
travoprost ophthalmic solution drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | travoprost ophthalmic solution | 42571-130 |
| Gland Pharma Limited | travoprost ophthalmic solution | 68083-601 |
| Mylan Pharmaceuticals Inc | travoprost ophthalmic solution, 0.004% | 0378-9651 |
| >Company | >Ingredient | >NDC |
travoprost ophthalmic solution drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Inc | travoprost ophthalmic solution usp, 0.004% | 62332-510 |
| >Company | >Ingredient | >NDC |
Excipient focus: TROMETHAMINE
travoprost ophthalmic solution drug variants containing TROMETHAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Inc | travoprost ophthalmic solution usp, 0.004% | 62332-510 |
| >Company | >Ingredient | >NDC |
travoprost ophthalmic solution drug variants not containing TROMETHAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | travoprost ophthalmic solution | 42571-130 |
| Gland Pharma Limited | travoprost ophthalmic solution | 68083-601 |
| Mylan Pharmaceuticals Inc | travoprost ophthalmic solution, 0.004% | 0378-9651 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
travoprost ophthalmic solution drug variants containing WATER
travoprost ophthalmic solution drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC CHLORIDE
travoprost ophthalmic solution drug variants containing ZINC CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | travoprost ophthalmic solution | 42571-130 |
| Gland Pharma Limited | travoprost ophthalmic solution | 68083-601 |
| Mylan Pharmaceuticals Inc | travoprost ophthalmic solution, 0.004% | 0378-9651 |
| >Company | >Ingredient | >NDC |
travoprost ophthalmic solution drug variants not containing ZINC CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Inc | travoprost ophthalmic solution usp, 0.004% | 62332-510 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
